ROBYN Study - Robotic Assisted Surgery in Gynecological Indications Compared to Conventional Laparoscopy

Sponsor
Intuitive Surgical (Industry)
Overall Status
Not yet recruiting
CT.gov ID
NCT05496244
Collaborator
(none)
5,000
97

Study Details

Study Description

Brief Summary

Robotic Assisted Surgery (da Vinci System) in gynecological indications compared to conventional laparoscopy

Condition or Disease Intervention/Treatment Phase
  • Device: Laparoscopy
  • Device: Robotic-assisted surgery

Detailed Description

A Prospective, Non-Interventional, Multinational, Post-Market Clinical Investigation

Study Design

Study Type:
Observational
Anticipated Enrollment :
5000 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
ROBYN Study - Robotic Assisted Surgery in Gynecological Indications Compared to Conventional Laparoscopy - A Prospective, Non-Interventional, Multinational, Post-Market Clinical Investigation
Anticipated Study Start Date :
Nov 1, 2022
Anticipated Primary Completion Date :
Nov 1, 2026
Anticipated Study Completion Date :
Dec 1, 2030

Arms and Interventions

Arm Intervention/Treatment
Epidemiological Section

Consecutive enrollment of patients with indications of interest

Observational Section

Extended data collection on patients treated via conventional laparoscopy or robotic-assisted surgery

Device: Laparoscopy
Laparoscopic surgery

Device: Robotic-assisted surgery
Robotic-assisted surgery

Outcome Measures

Primary Outcome Measures

  1. Describe treatment decision [Enrollment Completion]

    Describe treatment decision for the procedure of choice

  2. Describe patient outcome [12 Months]

    Describe patient outcome from robotic-assisted surgery and conventional laparoscopy by using physiological parameter such as relief or improvement of symptoms, number of complications or number of re-operations and changes in the patient reported quality of life (EQ-5D-5L) between baseline and FU at 12 Months (changes in the score)

  3. Describe impact of patient factors on outcome [12 Months]

    Describe impact of patient factors on outcome by using physiological parameter, such as age, BMI, uterus size, report co-morbidities

  4. Complications of medical interest [90 days]

    Describe complication of medical interest

Secondary Outcome Measures

  1. Quality of Life Impact per patient reported questionnaires [12 Months]

    Describe Quality of Life impact as assessed via patient reported questionnaires; changes in quality of life questionnaires scores between baseline and up to follow-up 12 months will be assessed (EQ-5D-5L on mobility, self-care, usual activities, pain/discomfort, anxiety/depression)

  2. Describe the impact of surgeon experience on outcome [12 Months]

    Describe the impact of surgeon experience on outcome; individual surgeon experience will be collected (self-reported by surgeon) and linked to every performed procedure; descriptive assessment if the reported surgeon experience has an impact on the outcome, e.g. number of reported complications. As surgeon experience, the number of performed procedures per indication and technique (robotic-assisted surgery or laparoscopy will be collected), as well as the overall years the surgeon is performing surgeries.

  3. Describe the performance and use of Intuitive instruments [12 Months]

    Describe the performance and use of Intuitive instruments; information on any device failure or device deficiency will be collected and descriptively assessed

  4. Describe the performance and use of Intuitive systems [12 Months]

    Describe the performance and use of Intuitive systems; information on any device failure or device deficiency will be collected and descriptively assessed

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
No
Key Inclusion Criteria:
  • Patient is willing to participate and to comply with the study procedures

  • Patient present with gynecological disease that may be treated with surgical intervention

Key Exclusion Criteria:
  • Life expectancy for less than 1 year

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • Intuitive Surgical

Investigators

  • Principal Investigator: Ingolf Juhasz-Böss, Prof. Dr., Universitätsklinikum Freiburg, Germany
  • Principal Investigator: Vincent Lavoué, Prof. Dr., CHU de Rennes, France

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Intuitive Surgical
ClinicalTrials.gov Identifier:
NCT05496244
Other Study ID Numbers:
  • 1.0
First Posted:
Aug 11, 2022
Last Update Posted:
Aug 11, 2022
Last Verified:
Aug 1, 2022
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
Yes
Product Manufactured in and Exported from the U.S.:
Yes

Study Results

No Results Posted as of Aug 11, 2022